Bristol Myers Squibb, insitro partner to develop treatments for neurodegenerative disorders

This article was originally published here

Under the deal, Bristol Myers Squibb and insitro will focus on the discovery and development of novel therapies to treat amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

The post Bristol Myers Squibb, insitro partner to develop treatments for neurodegenerative disorders appeared first on Pharmaceutical Business review.